Scientific and Clinical Center for Pediatric Hematology, Oncology and Immunology, Dmitry Rogachev National Medical Research Center of National Research Center for Oncology and Immunology

The Dmitry Rogachev National Scientific and Practical Center for Pediatric Hematology, Oncology and Immunology (NNPC DGOI named after Dmitry Rogachev) was founded in 1991 on the basis of the hematology department of the Russian Children's Clinical Hospital. The Center provides specialized high-tech medical care to children of all constituent entities of the Russian Federation aged 7 days to 18 years. The main task of the Dmitry Rogachev National Research Center for Pediatrics is not only to effectively treat children in inpatient and outpatient settings, but also to develop and implement uniform internationally recognized protocols for the treatment of blood diseases, malignant neoplasms, pathologies of the immune system and other severe ailments. The Center is the "locomotive" of the development of pediatric hematology-oncology in the Russian Federation. With the direct participation of leading specialists of the Center, regional centers for pediatric hematology and oncology have already been created and continue to be created in Russia.

History

2023

Discovery of the Nuclear Medicine Corps

In November 2023, a new building of nuclear medicine was opened at the Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology. On November 8, 2023, this institution was visited by President RFVladimir Putin.

In the new building, the first departments of pediatric neuro-oncology, head and neck surgery, a modern hybrid operating room, and an intensive care unit will be opened in Russia. The newly introduced nuclear medicine corps has no analogues in the children's oncology and hematology service in Russia. The introduced innovations will allow him to remain unique in the coming decades, - commented Galina Novichkova, General Director of the National Medical Research Center DGOI named after Dmitry Rogachev.

Vladimir Putin during the visit of the new nuclear medicine corps to the FNCC DGOI

According to the head of the department, radiologist of the positron emission tomography department Yuri Likar, the unique building was first launched in a children's clinic. As a result, doctors had the opportunity to make their own different radiopharmaceuticals and conduct research on modern PET/CT devices. According to him, this allows specialists to visualize small tumors or metastases, which is especially important for patients with oncology.

As noted in Rosatom, the construction of the building was carried out using modern information modeling technologies based on the customer's requirements. The use of such tools made it possible to track the entire life cycle of the facility - from design to operation - increasing control and minimizing risks.

The government allocated 2.6 billion rubles for the construction of the nuclear medicine building at the Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology. It was planned to put the facility into operation in 2022, but construction was delayed.^[1]

Construction of the Nuclear Medicine Building

Rosatom has completed the construction of the nuclear medicine building at the Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology. This was announced by the general director of the state corporation Alexei Likhachev on August 14, 2023 during a working meeting with President RFVladimir Putin.

Completed construction and commissioning work in the nuclear medicine building at the Dmitry Rogachev Center. I hope that in the fall [2023] he will receive the first patients, there many works have been completed ahead of schedule, - said Likhachev (quoted by RIA Novosti).

According to him, Rosatom is ready for serial production of equipment for nuclear medicine. In addition, despite all the difficulties, Rosatom retains 30% in the world market of isotopes for medical purposes, said the general director of the atomic state corporation.

On the lower floors of the nuclear medicine building at the Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology, laboratories, diagnostic units, and wards for the treatment of radionuclide drugs will be located. Here will also be the heart of the building - a room with cyclotron PETtrace 880 from GE Healthcare. On the high-precision accelerator of charged particles plan to develop radioisotopes 18F, 68Ga, 123I, 124I, 89Zr, 64Cu to make radiopharmaceuticals for diagnostics and treatment. They will be produced at the center, as well as carry out research work with FPM based on solid-state targets.

The maximum number of patients who can be diagnosed on two PET/CT scanners is 10 thousand per year. The Biograph Vision 450 PET/CT system was purchased from Siemens, and the Discovery PET/CT system PET PET/CT 710 was purchased from GE Healthcare.^[2]

Notes